Sign In

Allan Camaisa

CEO & Chair of the Board, Calidi Biotherapeutics

Professional Background

Allan Camaisa is a distinguished serial entrepreneur and investor, known for his robust leadership and visionary approach within the technology and healthcare sectors. With an impressive track record of success, Allan has spearheaded the growth of numerous startups, resulting in four successful exits through strategic sales to publicly traded Fortune 1000 companies. His focus on creating significant returns for his shareholders is reflected in his ability to cultivate effective teams and foster cultures of trust and collaboration within his organizations.

Currently serving as the Chairman and CEO of Calidi Biotherapeutics, a cutting-edge biopharmaceutical company, Allan has achieved noteworthy milestones during his tenure. Under his leadership, Calidi Biotherapeutics has signed a significant agreement with the prestigious National Institutes of Health (NIH) and has successfully recruited top immunologists to its Scientific Advisory Board. In addition, Allan has been instrumental in leading license negotiations with large pharmaceutical organizations, positioning Calidi at the forefront of therapeutic innovation.

Prior to his role at Calidi, Allan made significant contributions as the CEO and Chairman of Parallel6, Inc., where he oversaw the development of a revolutionary digital mobile software platform. This platform was designed to engage clinical trial participants effectively, enhancing the overall enrollment, management, and retention processes of participants for various pharmaceutical organizations. The high-impact work at Parallel6 led to its acquisition by PRA Health Sciences in 2017, solidifying Allan's reputation in the industry. Notably, esteemed clients of the platform included major corporations such as Sanofi, Genentech, Johnson & Johnson, and Pfizer, highlighting the extensive reach and credibility of the company under his guidance.

In 2005, Allan founded Anakam, Inc., a software security firm committed to safeguarding digital medical records in healthcare. Anakam delivered government-level multifactor authentication and security services, establishing a global license with the Veterans Administration (VA) for secure access to its primary patient portal, My HealtheVet. The firm was also recognized for its rapid growth, earning a spot on the INC 500 list and was subsequently acquired by Equifax in 2010.

Earlier in his career, Allan founded High Technology Solutions (HTS), which he grew from a small startup of two employees to a robust company with over 500 staff and $50 million in revenue. Recognized as an INC 500 company for three consecutive years, HTS was successfully sold to Wireless Facilities, Inc. (now known as Kratos Defense) in 2004.

Education and Achievements

Allan's educational background is as impressive as his entrepreneurial accomplishments. He studied Executive Education in the Owners Presidents Managers Program at Harvard Business School, acquiring insights and skills that have further empowered his leadership abilities and business acumen. Additionally, Allan holds a Bachelor’s Degree in Engineering from the prestigious United States Naval Academy, providing him with a solid foundation in both technical expertise and discipline.

Throughout his career, Allan has received numerous accolades that reflect his outstanding contributions to the field of technology and entrepreneurship. He is a proud recipient of awards such as the Deloitte FAST 50, the Governor’s Small Business of the Year Award, and the Ernst and Young Regional Entrepreneur of the Year Award. These honors underscore his consistent dedication to excellence and his notable impact on the industry. Furthermore, Allan has also been recognized by the San Diego Asian Business Association among multiple other organizations, showcasing his influential presence within the entrepreneurial community.

Achievements

Allan Camaisa’s career is marked by several remarkable achievements:

  • Four successful exits to Fortune 1000 companies, yielding substantial returns for shareholders.
  • Innovative leadership as CEO and Chairman of Calidi Biotherapeutics, including significant agreements with NIH.
  • Successful development and sale of Parallel6, Inc. to PRA Health Sciences in 2017, enhancing clinical trial processes for major pharmaceutical companies.
  • Founding of Anakam, Inc., which secured critical partnerships with organizations like the Veterans Administration and was recognized as one of the fastest-growing companies by INC 500 before being acquired by Equifax.
  • Growth of High Technology Solutions from 2 employees to over 500, recognized as an INC 500 company while scaling revenue to $50 million.
  • Ownership of seven U.S. patents, reflecting his innovative contributions to technology and healthcare solutions.
  • Distinguished military service as a surface warfare officer in the United States Navy, embodying leadership and commitment to service.

Conclusion

With a wealth of experience, recognized achievements, and a commitment to advancing technology in healthcare and beyond, Allan Camaisa continues to be a driving force in the entrepreneurial landscape.

Related Questions

How did Allan Camaisa develop his expertise in biotechnology and therapeutics?
What inspired Allan Camaisa to pursue a career in entrepreneurship?
In what ways has Allan Camaisa's military background influenced his leadership style and business practices?
What strategies did Allan Camaisa employ to ensure the success of his startups?
How has Allan Camaisa contributed to the field of digital security in healthcare through his ventures?
Allan Camaisa
Add to my network

Location

San Diego, California, United States